Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) FCF Margin (2016 - 2025)

Nephros has reported FCF Margin over the past 16 years, most recently at 4.86% for Q4 2025.

  • Quarterly results put FCF Margin at 4.86% for Q4 2025, down 2883.0% from a year ago — trailing twelve months through Dec 2025 was 8.76% (up 1223.0% YoY), and the annual figure for FY2025 was 8.76%, up 1262.0%.
  • FCF Margin for Q4 2025 was 4.86% at Nephros, up from 2.08% in the prior quarter.
  • Over the last five years, FCF Margin for NEPH hit a ceiling of 33.7% in Q4 2024 and a floor of 84.81% in Q1 2022.
  • Median FCF Margin over the past 5 years was 6.11% (2021), compared with a mean of 7.9%.
  • Biggest five-year swings in FCF Margin: soared 10390bps in 2021 and later tumbled -8196bps in 2022.
  • Nephros' FCF Margin stood at 12.35% in 2021, then skyrocketed by 38bps to 7.62% in 2022, then fell by -10bps to 8.39% in 2023, then surged by 502bps to 33.7% in 2024, then tumbled by -86bps to 4.86% in 2025.
  • The last three reported values for FCF Margin were 4.86% (Q4 2025), 2.08% (Q3 2025), and 22.49% (Q2 2025) per Business Quant data.